The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis

Fitness Costs of Drug Resistance Mutations in Multidrug-ResistantMycobacterium tuberculosis: A Household-Based Case-Control Study

(2015) Phillip P. Salvatore et al.   JOURNAL OF INFECTIOUS DISEASES

Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study

(2015) Louis Grandjean et al.   PLOS MEDICINE

Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy

(2014) Andrej Trauner et al.   DRUGS

Evolution and transmission of drug-resistant tuberculosis in a Russian population

(2014) Nicola Casali et al.   NATURE GENETICS

Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis

(2014) Sourya Shrestha et al.   Open Forum Infectious Diseases

Multidrug-Resistant Tuberculosis in Panama Is Driven by Clonal Expansion of a Multidrug-Resistant Mycobacterium tuberculosis Strain Related to the KZN Extensively Drug-Resistant M. tuberculosis Strain from South Africa

(2013) F. Lanzas et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemic Spread of Multidrug-Resistant Tuberculosis in Johannesburg, South Africa

(2013) B. J. Marais et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data

(2013) Dennis Falzon et al.   LANCET INFECTIOUS DISEASES

Advances in the development of new tuberculosis drugs and treatment regimens

(2013) Alimuddin Zumla et al.   NATURE REVIEWS DRUG DISCOVERY

Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis

(2012) Lukas Fenner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Putative Compensatory Mutations in the rpoC Gene of Rifampin-Resistant Mycobacterium tuberculosis Are Associated with Ongoing Transmission

(2012) M. de Vos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010

(2012) Matteo Zignol et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Modeling the Dynamic Relationship Between HIV and the Risk of Drug-Resistant Tuberculosis

(2012) R. Sergeev et al.   Science Translational Medicine

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

(2011) Christopher B Ford et al.   NATURE GENETICS

Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes

(2011) Iñaki Comas et al.   NATURE GENETICS

Mycobacterium tuberculosis Beijing genotype: A template for success

(2011) M. Hanekom et al.   TUBERCULOSIS

The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa

(2010) Thomas R Ioerger et al.   BMC GENOMICS

Antibiotic resistance and its cost: is it possible to reverse resistance?

(2010) Dan I. Andersson et al.   NATURE REVIEWS MICROBIOLOGY

EVOLUTIONARY EPIDEMIOLOGY AND THE DYNAMICS OF ADAPTATION

(2009) Sylvain Gandon et al.   EVOLUTION

The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis

(2009) F. Luciani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mathematical models of the epidemiology and control of drug-resistant TB

(2009) Ted Cohen et al.   Expert Review of Respiratory Medicine